Home > Press > NanoBusiness 2007 Announces Keynotes from World-Renowned Investors Wilbur Ross and Josh Wolfe
Investing Luminaries Wilbur Ross and Josh Wolfe to Deliver Opening and Closing Keynotes at NanoBusiness Investors Forum, April 17th in NYC
NanoBusiness 2007 Announces Keynotes from World-Renowned Investors Wilbur Ross and Josh Wolfe
New York, NY | Posted on March 26th, 2007
The NanoBusiness Alliance today announced that Wilbur Ross, chairman and CEO of W.L. Ross & Co., and Josh Wolfe, co-founder and Managing Partner of Lux Capital will be delivering keynotes at the NanoBusiness 2007 Conference at the Marriott Marquis in Times Square, New York City from April 15 - 17, 2007.
Billionaire investor Wilbur L. Ross Jr. will open the conference by discussing the potential of nanotechnology as a source of innovative products and solutions for established industries. Ross, who is also Chairman of the Board and an investor in Nano-Tex, was one of the first financiers to recognize the investment opportunities presented by this promising technology and has expressed his concern at the lack of technology innovation in established manufacturing industries. His belief in the transformational potential of nanotech has led him to enter a general partnership with Masters Capital Nanotechnology, a firm with multiple investments in companies with nano-enabled products. "Being able to see the investment potential of young nanotech companies can be challenging," commented Ross, "but I believe that many of our large ‘old economy' businesses will become nano companies out of a need for innovation and this will drive significant returns for shrewd investors in this sector."
The closing keynote for NanoBusiness 2007 will be delivered by Josh Wolfe, a pioneer in emerging technology investment with Lux Capital and editor of the Forbes/Wolfe Nanotech Report. Wolfe will share his broad perspective on the investment climate for nanotechnology-enabled companies and his predictions for which applications will be on the leading-edge of commercialization in the coming years. "Nanotechnology is leading the next wave of innovation and entrepreneurship," said Wolfe. "Investors must be informed and aware of the challenges and opportunities or risk being seriously disadvantaged."
"Our opening and closing keynotes illustrate how nanotechnology business today is being driven both by long-standing, established investors, as well as those who are squarely focused on emerging technology," said Vincent Caprio, Vice President and Event Director for the NanoBusiness Alliance. "We're proud to welcome Mr. Ross and Mr. Wolfe to our esteemed family of presenters."
Set in the heart of New York City, the NanoBusiness 2007 conference will bring together financial luminaries from Wall Street like Wilbur Ross and the CEOs of the most promising nanotechnology companies in the industry. These companies are on the frontier of global innovation in sectors such as "cleantech" - renewable energy and clean water, advanced materials, healthcare, defense, textiles, electronics and construction. The conference focuses on the commercial aspects of nanotechnology in each of these sectors and provides a forum for capital providers and innovators to meet, build relationships and learn from each other's perspectives.
For complete event information, please visit http://www.nanobusiness2007.com . For information on sponsoring or exhibiting at NanoBusiness 2007, please contact Vincent Caprio - .
About NanoBusiness Alliance
The NanoBusiness Alliance is the industry association for the emerging nanotechnology industry. Through its extensive network of leading startups, Fortune 500 companies, research institutions, non-governmental organizations and public-private partnerships, the Alliance shapes nanotechnology policy and helps accelerate the commercialization of nanotechnology innovations. The NanoBusiness Alliance has offices in Chicago, New York, Connecticut and Washington, DC. For more information, visit http://www.nanobusiness.org .
Complete event information can be found online at http://www.nanobusiness2007.com .
For more information, please click here
Schwartz Public Relations
Steven Wright-Mark, 212-677-8700 ext. 29
Copyright © Business Wire 2007
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Nano Labs Shareholder Update March 8th, 2014
FEI Company Announces Date for Investor Conference Participation March 3rd, 2014
Industrial Nanotech, Inc. Completes On Site Visit by PCAOB Audit Firm - Nears Completion of Audit in Preparation for Move to a Senior Stock Exchange in Late 2014 February 27th, 2014
Harris & Harris Group Announces the Consulting Engagement of Peter J. Boni as a Senior Advisor February 26th, 2014
Carbon Nanotubes Market by Type (SWCNTS & MWCNTS), Application (Electronics, Chemicals, Energy, Medical, Composites, Aerospace & more) & Geography - Global Trends & Forecasts To 2018 March 9th, 2014
Toxicity of Commonly-Used Nanoparticles on Human Body Studied in Iran March 9th, 2014
Aptasensors Help Detection of Cancer Protein Marker March 9th, 2014
Nano Labs Shareholder Update March 8th, 2014
Singapore's A*STAR IME will present 9 papers in optical device innovation and foundry-qualified platform development at world-class optical communications conference March 6th, 2014
How 19th Century Physics Could Change the Future of Nanotechnology: University of Cincinnati physics researchers have developed a new way of using an old technique that could help build better nanotechnology March 5th, 2014
Malvern Instruments announces guest presenter for March 18th protein characterization webinar: Renowned protein scientist Prof. Dr. John F. Carpenter shows how combining Dynamic Light Scattering with Raman Spectroscopy delivers new insights in protein stability, aggregation... March 4th, 2014
UC research tests which nano system works best in killing cancer cells: New UC research to be presented this week tested four iron-oxide nanoparticle systems to see which, when heated, would likely work best as a tool for targeting cancer cells March 4th, 2014